Boston Scientific unveils drug-coated stent

05/19/2009 | Boston Globe (tiered subscription model), The

Boston Scientific has introduced in select global markets its TAXUS Element Paclitaxel-Eluting Coronary Stent System. The device uses platinum chromium alloy designed for coronary stent purposes and "represents the company's third-generation drug-eluting stent technology," Boston Scientific said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC